Indication
Bone or Joint Infection
1 clinical trial
2 products
Product
AfabicinClinical trial
Randomized Open-label Active-controlled Study to Assess the Safety, Tolerability, and Efficacy of Afabicin IV/Oral in the Treatment of Patients With Bone or Joint Infection Due to StaphylococcusStatus: Recruiting, Estimated PCD: 2026-12-01
Product
Standard of Care